Invivyd (IVVD) Other Non-Current Assets (2021 - 2025)
Invivyd (IVVD) reported Other Non-Current Assets of $110000.0 for Q4 2025, up 223.53% on a YoY basis from $34000.0 in Q4 2024, and up 1733.33% quarter-over-quarter from $6000.0 in Q3 2025.
Invivyd (IVVD) Other Non-Current Assets (2021 - 2025) Analysis & Trends
Invivyd has reported Other Non-Current Assets for 5 years, with the latest figure at $110000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 223.53% year-over-year to $110000.0; the trailing twelve-month figure through Dec 2025 stood at $110000.0 (up 223.53% YoY), and the FY2025 full-year result was $110000.0, up 223.53% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $110000.0, up from $6000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $7.5 million in Q3 2024, with the low at $6000.0 in Q3 2025.
- Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $236500.0 in 2022.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 3885.03% — and 2025, when it slumped 99.92%.
- Invivyd's Other Non-Current Assets stood at $3.3 million in 2021, then sank by 94.21% to $191000.0 in 2022, then dropped by 8.38% to $175000.0 in 2023, then sank by 80.57% to $34000.0 in 2024, then jumped by 223.53% to $110000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $110000.0 (Q4 2025), $6000.0 (Q3 2025), and $15000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 110,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Sep 30, 2024 | 7.45 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 175,000.00 |
| Sep 30, 2023 | 187,000.00 |
| Jun 30, 2023 | 291,000.00 |
| Mar 31, 2023 | 291,000.00 |
| Dec 31, 2022 | 191,000.00 |
| Sep 30, 2022 | 236,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 237,000.00 |
| Dec 31, 2021 | 3.30 Mn |
| Sep 30, 2021 | 6.12 Mn |